Digital Biomarkers: Past, Present, and Future
· How are digital biomarkers being utilized to assess clinical outcomes and facilitate drug development?
· What initiatives are underway to help guide the validation and use of digital biomarkers?
· What challenges exist for the implementation of digital biomarkers?
· What are emerging applications for digital biomarkers and where is the field headed?
Discussion Leader:
Elena Izmailova (Koneska Health)
Organized by:
Lakshmi Amaravadi (Dewpoint Therapeutics), Carmen Fernández-Metzler (PharmaCadence), Karen Quadrini (Passage Bio)
00:44:35